Clinical Trials Browser

Phase 3 × Adenoma × Cabergoline × Clear all

NCT02288962 2025-06-08

Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas

Phase 3 Active not recruiting

Adenoma, Pituitary Neoplasms